Troxerutin ( Troxerutinum)
This medicine should always be used exactly as described in the patient leaflet or as directed by a doctor, pharmacist, or nurse.
Rutoven contains troxerutin, which has a protective effect on blood vessels by maintaining their elasticity and reducing their permeability. Rutoven is used to treat chronic venous insufficiency and its symptoms, such as swelling of the legs, feeling of heaviness, tingling, etc.
Before starting to use Rutoven, the patient should discuss it with their doctor, pharmacist, or nurse. Do not use on damaged skin.
The safety of using Rutoven in children has not been established. Before using the medicine in children, the patient should consult a doctor.
The patient should tell their doctor or pharmacist about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take. There is no data on interactions with other medicines.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before using this medicine. Due to the lack of data confirming safety, the use of the medicine during pregnancy and breastfeeding is not recommended.
Rutoven does not affect the ability to drive or use machines.
The medicine contains ethyl parahydroxybenzoate and may therefore cause allergic reactions (possible late-type reactions). The medicine also contains bronopol, which may cause local skin irritation (contact dermatitis) in sensitive individuals.
The medicine should be applied to the skin. A thin layer of gel should be applied to the skin in areas affected by venous insufficiency, swelling, feeling of heaviness, tingling, etc. Massage gently until fully absorbed. Use 3 times a day for 2-3 weeks. If the patient feels that the effect of the medicine is too strong or too weak, they should consult their doctor.
There is no information on overdose.
The patient should not use a double dose to make up for a missed dose. They should continue treatment according to the previously adopted schedule.
If the patient has any further doubts about using this medicine, they should consult their doctor, pharmacist, or nurse.
Like all medicines, Rutoven can cause side effects, although not everybody gets them. In sensitive individuals, skin redness, hives may occur. In some individuals, other side effects may occur during the use of Rutoven.
If the patient experiences any side effects, including any side effects not listed in the leaflet, they should inform their doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel. 48 22 49 21 301, fax 48 22 49 21 309, e-mail: ndl@urpl.gov.pl. By reporting side effects, more information can be gathered on the safety of the medicine.
Do not store above 25°C. The medicine should be stored out of sight and reach of children. Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the given month. The medicine should not be used 6 months after opening the tube. Medicines should not be disposed of via wastewater or household waste containers. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
The active substance of the medicine is troxerutin ( Troxerutinum) – 20 mg/g. The other ingredients (excipients) are: carbomer, sodium hydroxide, ethyl parahydroxybenzoate, bronopol, purified water.
Rutoven is a gel. The available packaging is an aluminum tube containing 30 g of gel, in a cardboard box.
Poznańskie Zakłady Zielarskie „Herbapol” S.A. ul. Towarowa 47/51, 61-896 Poznań, Poland tel. + 48 61 886 18 00, fax + 48 61 853 60 58 Date of last update of the leaflet:
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.